Department of Cardiovascular Diseases, Mayo College of Medicine, Rochester, MN (J.D.S.S., A.L.).
Division of Nephrology and Hypertension, Mayo Clinic, Rochester, MN (L.O.L.).
Hypertension. 2023 Dec;80(12):2515-2522. doi: 10.1161/HYPERTENSIONAHA.123.19418. Epub 2023 Oct 10.
Cardiovascular disease is often a disease of aging. Considerable advances in our understanding of the biological mechanisms of aging have been made; yet, cardiovascular disease remains the leading cause of death in the United States urging a continued search for novel risk factors to target for preventing and treating disease. Mental stress (MS) is emerging as an important risk factor, and while progress has been made in understanding the link between MS and cardiovascular disease, the precise mechanisms of a putative causal relationship require greater clarification. In the current review, we (1) summarize our current understanding of the pathological effects of MS on vascular health; (2) describe important aspects of the pathobiology of vascular aging including inflammation, oxidative stress, mitochondrial dysfunction as well as novel processes such as genomic instability, epigenetic alterations, and nutrient signal pathways; (3) highlight similarities in the downstream biologic effects of aging and MS on vascular health with an emphasis on cellular and molecular processes that could be used to develop novel prognostic markers and treatment strategies for cardiovascular disease; (4) discuss lifestyle and pharmacological methods that target indicators of aging whose role could be translated into approaches managing the effects of MS; and (5) outline important future steps that should be considered in this area of research including the need for prospective clinical trials and for creating greater collaboration between preclinical aging researchers and clinical investigators managing MS.
心血管疾病通常是一种衰老病。我们在理解衰老的生物学机制方面已经取得了相当大的进展;然而,心血管疾病仍然是美国的主要死亡原因,这促使我们继续寻找新的风险因素,以预防和治疗疾病。精神压力(MS)正在成为一个重要的风险因素,尽管我们已经在理解 MS 与心血管疾病之间的联系方面取得了进展,但确切的因果关系机制仍需要进一步澄清。在当前的综述中,我们(1)总结了我们目前对 MS 对血管健康的病理影响的理解;(2)描述了血管衰老的病理生物学的重要方面,包括炎症、氧化应激、线粒体功能障碍以及基因组不稳定性、表观遗传改变和营养信号通路等新过程;(3)强调了衰老和 MS 对血管健康的下游生物学效应的相似性,重点介绍了可能用于开发心血管疾病新预后标志物和治疗策略的细胞和分子过程;(4)讨论了针对衰老指标的生活方式和药理学方法,其作用可以转化为管理 MS 影响的方法;(5)概述了该研究领域中应考虑的重要未来步骤,包括需要前瞻性临床试验以及在管理 MS 的临床研究人员和基础衰老研究人员之间建立更大的合作。